Common use of Compliance with Nasdaq Continued Listing Requirements Clause in Contracts

Compliance with Nasdaq Continued Listing Requirements. The Company is and has no reason to believe that it will not, upon the issuance of the Securities hereunder, continue to be, in compliance with the listing and maintenance requirements for continued listing on NASDAQ. Assuming the representations and warranties of the Purchasers set forth in Section 4.2 are true and correct in all material respects, the consummation of the transactions contemplated by the Transaction Documents does not contravene the rules and regulations of NASDAQ. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any notice of, nor to the Company’s knowledge is there any basis for, the delisting of the Common Stock from NASDAQ.

Appears in 4 contracts

Samples: Securities Purchase Agreement (Second Sight Medical Products Inc), Securities Purchase Agreement (Second Sight Medical Products Inc), Securities Purchase Agreement (Second Sight Medical Products Inc)

AutoNDA by SimpleDocs

Compliance with Nasdaq Continued Listing Requirements. The Company is is, and has no reason to believe that it will not, upon the issuance of the Securities hereunder, continue to be, in compliance with the listing and maintenance requirements for continued listing on NASDAQNasdaq. Assuming the representations and warranties of the Purchasers set forth in Section 4.2 are true and correct in all material respects, the consummation of the transactions transaction contemplated by the Transaction Documents does not contravene the rules and regulations of NASDAQNasdaq. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ Nasdaq and the Company has not received any notice of, nor to the Company’s knowledge is there any basis for, the delisting of the Common Stock from NASDAQNasdaq except as disclosed in Schedule 3.24.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Vermillion, Inc.), Securities Purchase Agreement (Strobeck Matthew), Securities Purchase Agreement (Feinberg Family Trust)

Compliance with Nasdaq Continued Listing Requirements. The Company is is, and has no reason to believe that it will not, upon the issuance of the Securities hereunder, continue to be, in compliance with the listing and maintenance requirements for continued listing on NASDAQ. Assuming the representations and warranties of the Purchasers set forth in Section 4.2 are true and correct in all material respects, the consummation of the transactions contemplated by the Transaction Documents does not contravene the rules and regulations of NASDAQ. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any notice of, nor to the Company’s knowledge is there any basis for, the delisting of the Common Stock from NASDAQ.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Pulse Biosciences, Inc.), Securities Purchase Agreement (Pulse Biosciences, Inc.), Securities Purchase Agreement (Duggan Robert W)

Compliance with Nasdaq Continued Listing Requirements. The Company is is, and has no reason to believe that it will not, upon the issuance of the Securities hereunder, continue to be, in compliance with the listing and maintenance requirements for continued listing on NASDAQNasdaq in all material respects. Assuming the representations and warranties of the Purchasers set forth in Section 4.2 are true and correct in all material respects, the consummation of the transactions contemplated by the Transaction Documents does not contravene the rules and regulations of NASDAQNasdaq. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ Nasdaq and the Company has not received any notice of, nor to the Company’s knowledge is there any basis for, the delisting of the Common Stock from NASDAQNasdaq.

Appears in 2 contracts

Samples: Securities Purchase Agreement (GTX Inc /De/), Securities Purchase Agreement (GTX Inc /De/)

Compliance with Nasdaq Continued Listing Requirements. The Company is is, and has no reason to believe that it will not, upon the issuance of the Securities hereunder, continue to be, in compliance with the listing and maintenance requirements for continued listing on NASDAQThe Nasdaq Capital Market. Assuming the representations and warranties of the Purchasers Purchaser set forth in Section 4.2 are true and correct in all material respects, the consummation of the transactions contemplated by the Transaction Documents does not contravene the rules and regulations of NASDAQNasdaq. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ The Nasdaq Capital Market and the Company has not received any notice of, nor to the Company’s knowledge is there any basis for, the delisting of the Common Stock from NASDAQNasdaq.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Pulse Biosciences, Inc.), Securities Purchase Agreement (Pulse Biosciences, Inc.)

Compliance with Nasdaq Continued Listing Requirements. The Company is is, and has no reason to believe that it will not, upon the issuance of the Securities hereunder, continue to be, in compliance with the listing and maintenance requirements for continued listing on NASDAQNASDAQ in all material respects. Assuming the representations and warranties of the Purchasers set forth in Section 4.2 are true and correct in all material respects, the consummation of the transactions contemplated by the Transaction Documents does not contravene the rules and regulations of NASDAQ. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any notice of, nor to the Company’s knowledge is there any basis for, the delisting of the Common Stock from NASDAQ.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Enphase Energy, Inc.), Securities Purchase Agreement (Enphase Energy, Inc.)

AutoNDA by SimpleDocs

Compliance with Nasdaq Continued Listing Requirements. The Company is is, and has no reason to believe that it will not, upon the issuance of the Securities hereunder, continue to be, in compliance with the listing and maintenance requirements for continued listing on NASDAQNasdaq. Assuming the representations and warranties of the Purchasers set forth in Section 4.2 are true and correct in all material respects, the consummation of the transactions contemplated by the Transaction Documents does not contravene the rules and regulations of NASDAQNasdaq. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ Nasdaq and the Company has not received any notice of, nor to the Company’s knowledge is there any basis for, the delisting of the Common Stock from NASDAQNasdaq.

Appears in 1 contract

Samples: Securities Purchase Agreement (Hansen Medical Inc)

Compliance with Nasdaq Continued Listing Requirements. The Company is is, and has no reason to believe that it will not, upon the issuance of the Securities hereunder, continue to be, in compliance with the listing and maintenance requirements for continued listing on NASDAQNasdaq. Assuming the representations and warranties of the Purchasers Warrantholders set forth in Section 4.2 are true and correct in all material respects, the consummation of the transactions contemplated by the Transaction Documents does not contravene the rules and regulations of NASDAQNasdaq. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ Nasdaq and the Company has not received any notice of, nor to the Company’s knowledge is there any basis for, the delisting of the Common Stock from NASDAQNasdaq.

Appears in 1 contract

Samples: Exchange Agreement (Hansen Medical Inc)

Compliance with Nasdaq Continued Listing Requirements. The Company is is, and has no reason to believe that it will not, upon the issuance of the Securities hereunderNotes, or the Shares upon conversion of the Notes, continue to be, in compliance with the listing and maintenance requirements for continued listing on NASDAQNASDAQ in all material respects. Assuming the representations and warranties of the Purchasers Purchaser set forth in Section 4.2 are true and correct in all material respects, the consummation of the transactions contemplated by the Transaction Documents does not contravene the rules and regulations of NASDAQ. There are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any notice of, nor to the Company’s knowledge is there any basis for, the delisting of the Common Stock from NASDAQ.

Appears in 1 contract

Samples: Securities Purchase Agreement (Enphase Energy, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.